Aurora Cannabis wins rights for licensing talks with CannaRoyalty

(Reuters) – Canadian medical marijuana maker Aurora Cannabis Inc has won the rights to negotiate a licensing deal with CannaRoyalty Corp that will allow it to sell a range of cannabis-infused consumer products.

Aurora — one of the biggest Canadian cannabis companies — has an exclusive right for 90 days to hammer out a licensing agreement that could give it the rights to sell inhalers, transdermal patches, gels and lotions.

Aurora, which currently only makes medical cannabis, has been seeking deals to offer more products including consumer-oriented products like ones offered by CannaRoyalty, a small Ottawa-based firm.

Alberta-based Aurora is also trying to buy fellow medical marijuana firm CanniMed Therapeutics.

The deals come amid expectations that Canada will soon legalize the production, sale and consumption of recreational marijuana.

Reporting by John Benny in Bengaluru

Our Standards:The Thomson Reuters Trust Principles.

Continue reading at Reuters.com

About Reuters

Since 1850, we have experimented, invented, and created content and news solutions to become the world’s leading international news agency. Always at the forefront of real-time breaking news and high-impact global multimedia content, we are constantly innovating our products and services to meet your business needs. Whether we are serving broadcasters, publishers, brands, agencies, or direct to consumers, Reuters provides award-winning coverage of the day’s most important topics, including: business, finance, politics, sports, entertainment, technology, health, environment, and much more.

Leave a Reply

Your email address will not be published. Required fields are marked *